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ABSTRACT 
 
Since carnitine plays an important role in fat oxidation, influx of carnitine could be crucial for 
muscle metabolism. OCTN2 (SLC22A5), a sodium-dependent solute carrier, is assumed to 
transport carnitine into skeletal muscle cells. Acute regulation of OCTN2 activity in rat hindlimb 
muscles was investigated in response to electrically induced contractile activity. The tissue uptake 
clearance (CLuptake) of L-[
3
H]carnitine during muscle contraction was examined in vivo using 
integration plot analysis. The CLuptake of [
14
C]iodoantipyrine (IAP) was also determined as an 
index of tissue blood flow. To test the hypothesis that increased carnitine uptake involves the 
translocation of OCTN2, contraction-induced alteration in the subcellular localization of OCTN2 
was examined. The CLuptake of L-[
3
H]carnitine in the contracting muscles increased 1.4–1.7 fold 
as compared to that in the contralateral resting muscles (p < 0.05). The CLuptake of [
14
C]IAP was 
much higher than that of L-[
3
H]carnitine, but no association between the increase in carnitine 
uptake and blood flow was obtained. Co-immunostaining of OCTN2 and dystrophin (a muscle 
plasma membrane marker) showed an increase in OCTN2 signal in the plasma membrane after 
muscle contraction. Western blotting showed that the level of sarcolemmal OCTN2 was greater in 
contracting muscles than in resting muscles (p < 0.05). The present study showed that muscle 
contraction facilitated carnitine uptake in skeletal muscles, possibly via the contraction-induced 
translocation of its specific transporter OCTN2 to the plasma membrane. 
 
Key words: carnitine transporter, electrical stimulation, uptake clearance, subcellular localization, 
skeletal muscle 
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Abbreviations  
 
CLint, intrinsic clearance; 
CLuptake, uptake clearance; 
GAPDH, glyceraldehyde-3-phosphate dehydrogenase; 
GasD, the deep portions of the gastrocnemius; 
GasS, the surface portions of the gastrocnemius; 
IAP, iodoantipyrine; 
MCT4, monocarboxylate transporter 4; 
OCTN2, carnitine/organic cation transporter; 
OME, outer membrane-enriched fraction; 
Pla, muscle plantaris;  
Sol, muscle soleus 
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INTRODUCTION 
 
Carnitine is essential for the transport of long-chain fatty acyl groups into the 
mitochondrial matrix for subsequent beta-oxidation [1,2]. Another important role that carnitine 
plays in skeletal muscles is regulation of the acetyl coenzyme A/free coenzyme A ratio by 
buffering excess acetyl groups from pyruvate oxidation that occurs during events such as 
vigorous exercise [3,4]. However, acetylation depletes the free carnitine pool, and may impair 
free fatty acid transport into the mitochondria. Therefore, free carnitine availability is an 
important factor in skeletal muscle metabolism [4,5].  
Carnitine metabolism during muscle contraction has not been well studied. Especially, 
its transport across the plasma membrane is not fully clarified. It is reported that during 
high-intensity exercise, there is a rapid depletion in the free carnitine level in the skeletal muscle, 
as free carnitine is used up in the production of acetylcarnitine [6]. Furthermore, previous studies 
in humans have revealed that carnitine metabolism and its exchange between the blood and 
muscle cells may occur during exercise. [5,7]. However, there is no evidence that muscle 
contraction per se augments carnitine uptake, and the regulatory mechanism of carnitine transport 
across the plasma membrane during muscle contraction remains unknown. 
Carnitine uptake into cells is mediated by a sodium-dependent high-affinity 
transporter—organic cation transporter (OCTN2/SLC22A5) [8]. Since the carnitine concentration 
in the skeletal muscle (2–4 mmol kg-1 wet muscle weight) is about 100 times higher than that in 
the plasma [9], carnitine should be transported into muscle cells against a considerable 
concentration gradient. Thus, the increase in plasma carnitine delivery per se (i.e., increased 
blood flow) does not account for an increase in carnitine influx into skeletal muscles. Recently, 
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we found that OCTN2 is expressed in rodent skeletal muscles, and comparison of various types 
of muscles indicated tight coupling of OCTN2 expression with carnitine uptake capacity of the 
muscle [10]. Therefore, OCTN2 could be responsible for the regulation of carnitine uptake during 
muscle contraction. However, our previous observation [10] was conducted on resting muscles, 
and carnitine uptake during muscle contraction, wherein tissue blood flow increases dramatically, 
still remains a question [11]. Therefore, in order to confirm that carnitine uptake by skeletal 
muscles during muscle contraction is regulated by OCTN2, and not by blood flow, we examined 
the effect of blood flow on tissue carnitine uptake.  
It is well known that uptake of glucose and fatty acids increases when the transporters 
(GLUT4 and FAT/CD36, respectively) are translocated to the plasma membrane by stimulation of 
muscle contraction [12]. Whether a similar mechanism can promote carnitine uptake has been 
never demonstrated. On the basis of our immunohistochemical analysis, it is likely that OCTN2 
can be translocated because OCTN2 localizes not only in the sarcolemma but also in the 
intracellular space (unpublished observation). Therefore, we investigated the hypothesis that 
muscle contraction induces upregulation of carnitine uptake, which is mediated by translocation 
of OCTN2 to the plasma membrane in this tissue. In the present study, muscle contraction was 
induced in a unilateral rat hindlimb by electrical stimulation, and the contralateral leg was 
considered as the resting leg. Integration plot analysis during muscle contraction was used to 
compare carnitine uptake clearance between the right and left legs. Furthermore, 
immunohistochemical analysis and were performed in order to detect changes in the subcellular 
localization of OCTN2 with/without muscle contraction. The present study is the first report to 
provide experimental evidence that contractile activity facilitates carnitine uptake through 
translocation of OCTN2 in the skeletal muscles. 
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MATERIALS AND METHODS 
 
Animals 
Male Wistar rats weighing 249 – 337 g (n = 25) were used for the experiment. A 
standard diet (Oriental Yeast Co., Tokyo, Japan) and water were provided ad libitum. All 
procedures performed in this study were approved by the Ethics Committee on Animal 





H]Carnitine (84 Ci mmol
-1
) was purchased from GE Healthcare (Piscataway, NJ), 
and [
14
C]inulin (1–3 mCi g-1) was purchased from PerkinElmer Life Sciences (Boston, MA). 
[
14
C]iodoantipyrine (IAP) (55 mCi mmol
-1
) was purchased from American Radiolabeled 
Chemicals Inc. (St. Louis, MO). Other reagents were obtained from Sigma Chemical Co. (St. 
Louis, MO), Wako Pure Chemical Industries, Funakoshi Co. (Tokyo, Japan) and GE Healthcare 
(Piscataway, NJ). 
 
Muscle contraction protocol 
All surgical procedures were performed with the animals under pentobarbital sodium 
anesthesia (50 mg kg
-1
 intraperitoneally). Under resting conditions, the left foot was attached to a 
clamp unit and connected to an electromotor system (Model RU-72, Nihon Koden, Tokyo, Japan). 
The right foot, with the contralateral resting muscle, was also clamped and lifted to the same 
height as the left foot. The ankle and knee joint were fixed at 90°. Isometric, tetanic muscle 
contractions were elicited in the left leg by electrostimulation via a surface electrode with trains 
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of stimuli (0.2-ms pulse duration at 40 Hz, 10 V, lasting for 0.2 s). The stimulation was applied at 
a rate of 1 contraction per second for 5 min.  
 
Experiment 1: Effect of muscle contraction on carnitine uptake 
Tissue uptake of carnitine 
The tissue distribution of L-[
3
H]carnitine was examined using the integration plot 
analysis as described previously [10,13]. Rats were anaesthetized, and isometric contraction of 
the left leg was induced by the method as described above section. Two minutes after the 
contraction started, L-[
3




C]inulin (0.73 mg kg
-1
) dissolved in 
saline was injected via the left jugular vein. At designated times, blood was withdrawn from the 
right jugular vein, and plasma was separated by centrifugation. Three minutes later (5 min after 
stimulation started), immediately after the electrical stimulation stopped, the rats were sacrificed. 
The right and left hindlimb muscles (m. soleus (Sol), m. plantaris (Pla), and the surface and deep 
portions of m. gastrocnemius (GasS and GasD, respectively)) were excised immediately. Each 
tissue sample was weighed and solubilized with Soluene-350
®
 (Packard Inc., Meriden, CT) at 
55°C for 3 h. The solution was treated with hydrogen peroxide and neutralized with 5 M HCl. 
The solubilized tissues and plasma were each mixed with Clearsol I (Nacalai Tesque Inc., Kyoto, 
Japan) as a scintillation liquid, and the corresponding radioactivity was measured with a liquid 
scintillation counter, LSC-5100 (Aloka, Tokyo, Japan). 
 Tissue uptake clearance (CLuptake) of L-[
3
H]carnitine was measured by integration plot 
analysis as described previously [10]. Assuming that the efflux of the radioactive compounds 
from the tissue is negligible, the tissue uptake clearance (CLuptake) can be obtained using the 
following equation: 
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XT(t)/Cp(t) = CLuptake · AUC(0–t)/Cp(t) + V0 
where XT(t) and Cp(t) are the amount and concentration of the compound in tissue and plasma, 
respectively, at time t. AUC(0–t) is the area under plasma concentration curve from time 0 to t. V0 
is the volume of distribution in which a rapid equilibrium with the plasma compartment.[10] 
In order to examine the effect of blood flow on carnitine uptake in muscles, a separate 
group of rats was used to assess tissue blood flow by the CLuptake of [
14
C]IAP. The blood flow rate 
was measured in the last 40 s of a 5-min muscle contraction by using the inert diffusible 
radiolabelled tracer [
14
C]IAP as described previously [14,15]. Briefly, the rats were anaesthetized 
and the muscle contraction procedure was performed for 5 min. Two minutes after the contraction 
started, L-[
3
H]carnitine (27.3 ng kg
-1
) was injected and blood was withdrawn from the right 
jugular vein at designated times. In the last 40 s of a 5-min muscle contraction, [
14
C]IAP (34.9 ng 
kg
-1
) dissolved in saline was intravenously injected. After intervals of 20 s and 35 s following 
injection, blood was withdrawn from the right jugular vein. After 40 s following injection, both 
the right and the left calf muscles were removed. The CLuptake of [
14
C]IAP was obtained as the 
slope of XT(t)/Cp(t) versus AUC/Cp(t) for [
14
C]IAP according to the above equation. 
Furthermore, to evaluate carnitine uptake capacity of the muscles, intrinsic clearance 
(CLint) representing the influx of L-[
3
H]carnitine across the plasma membranes was calculated 
from the following equation using the well-stirred model [16]: 
CLint = Q
．
 · CLuptake / (Q
．
 – CLuptake) 
where Q
．




Experiment 2: Effect of muscle contraction on the sarcolemmal OCTN2 content 
Isolation of outer membrane-enriched fraction 
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Immediately after electrically induced muscle contraction, the right and left hindlimb 
muscles were excised. GasD samples were separated into 2 membrane fractions—outer 
membrane-enriched fraction (OME) and intracellular fraction—by a modified protocol based on 
the method reported by Juel et al. [19]. Briefly, the GasD was minced and incubated for 30 min in 
buffer A (2 M NaCl, 20 mM HEPES, and 0.2 mM PMSF; pH 7.4). After incubation, the tissue 
was recovered by centrifugation and homogenized in buffer B (250 mM sucrose, 1 mM EDTA, 
20 mM HEPES, and 0.2 mM PMSF; pH 7.4) using a Polytron homogenizer (PT 1200 CL; 
Kinematica, Lucerne, Switzerland). The homogenate was centrifuged at 1,000 g for 5 min at 4°C, 
and then the supernatant was centrifuged at 10,000 g for 30 min at 4°C. The pellet (Fraction 1; 
F1) was resuspended in buffer B and saved. The supernatant was centrifuged again at 100,000 g 
for 30 min at 4°C. The pellet (Fraction 2; F2), the OME fraction, was resuspended in buffer B 
and used for western blotting. The supernatant (Fraction 3; F3) was also used. Isolation of 
sarcolemma was confirmed by Western blotting for monocarboxylate transporter 4 (MCT4), 
which is a plasma membrane protein.  
 
Western blotting 
Western blot analysis was performed as described previously [10]. Samples (10 µg 
lane
-1
) were separated by SDS-polyacrylamide gel electrophoresis on a 12% gel, and proteins 
were transferred to a polyvinylidene difluoride membrane (P-Membranes; ATTO, Tokyo, Japan). 
The membranes were blocked with Block Ace (DS Pharma Biomedical Co., Osaka, Japan) for 60 
min at room temperature, and then incubated with appropriate primary antibodies. The polyclonal 
antibody to MCT4 was obtained from Chemicon (Temecula, CA). Glyceraldehyde-3-phosphate 
dehydrogenase (GAPDH) (Abcam, Cambridge, MA) was used as a loading control. 
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Experiment 3: Effect of muscle contraction on subcellular localization of OCTN2 
Hindlimb perfusion and fixation 
Under anesthesia, the hindlimb perfusion was performed as described previously [17]. 
In brief, the rat was killed by injection of 1 M KCl solution into the heart, and Krebs-Henseleit 
buffer including 100 µM L-carnitine (Lonza Inc., VS, Switzerland) was perfused into the 
abdominal aorta in a flow-through mode at a constant flow (15 mL min
-1
). The flow rate was set 
at 22 mL min
-1
, and then isometric contraction was performed on the left hindlimb using the same 
protocol as described in the previous section. Immediately after muscle contraction, the 
hindquarters were perfused with 4% paraformaldehyde/phosphate buffer (pH 7.4) for 10 min.  
 
Immunohistochemical analysis 
The fixed hindlimbs were gently removed and left in fresh fixation buffer at 4°C 
overnight. After dehydration with sucrose in phosphate-buffered saline (PBS), tissue blocks were 
frozen rapidly in isopentane cooled by liquid nitrogen. Frozen sections (6 µm) of the isolated m. 
gastrocnemius were prepared as described previously [18]. Tissue sections were treated with 
Retrieve-All Antigen Unmasking System 1 (Covance, Princeton, NJ) for 10 min at 92°C to 
unmask the antigen. They were incubated with primary antibody diluted in blocking buffer at 4°C 
overnight and further incubated with secondary antibodies for 1 h at room temperature. The 
fluorescence was detected with a confocal laser scanning fluorescence microscope (LSM 710, 
Carl Zeiss, Göttingen, Germany). 
 
Statistical analysis 
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All data are expressed as mean ± standard error of the mean (SEM). Paired t-test was 
used to compare the right and left leg muscles. Relationships between the selected variables were 
examined using the Pearson product-moment correlation coefficient. The level of significance 
was set at p < 0.05. 
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RESULTS 
 
Experiment 1: Effects of muscle contraction on carnitine uptake 
Figure 1 shows the CLuptake of L-[
3
H]carnitine calculated from the integration plot in the 
4 calf muscles of the legs under resting and contracting conditions. The data were corrected by 
the radioactivity of [
14
C]inulin, which cannot permeate the membrane easily and is a marker of 
vascular and interstitial fluids [10]. For Sol, GasS, and GasD, the CLuptake of L-[
3
H]carnitine was 
significantly higher under contraction than under resting (p < 0.05). For Pla, the CLuptake tended to 
be greater under muscle contraction (p = 0.07). 




H]carnitine is shown in Table 1. These data were 
measured in separate animals from Figure 1, and the CLuptake of L-[
3
H]carnitine were not 
corrected by [
14
C]inulin. In the resting condition, the CLuptake of [
14
C]IAP was about 10-fold 
higher than that of L-[
3
H]carnitine. The CLuptake of [
14
C]IAP was 5.0–8.0-fold higher in the 
contracting muscles than in resting muscles (Table 1). No association was observed between the 




H]carnitine (r = 0.28, p = 0.23). 
The CLint of L-[
3
H]carnitine is also summarized in Table 1. For Sol, Pla, and GasD, the 
CLint of L-[
3
H]carnitine was significantly higher by 1.17–1.32-fold under contraction than under 
resting (p < 0.05). For GasS, however, the difference in the CLint of L-[
3
H]carnitine was not 
statistically significant (p = 0.07). 
 
Experiment 2: Effects of muscle contraction on subcellular distribution of OCTN2 
Fractions of the muscle samples (GasD) obtained by the centrifugation procedure 
described above were characterized immunologically. Following exposure to a high-salt 
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concentration, it was possible to separate sarcolemmal and other membrane fraction [20]. In the 
present study, we confirmed that MCT4 was present only in the plasma membrane fraction (F2), 
and not in the other fractions (F1 and F3, Fig. 2A) when muscles were incubated in 2 M NaCl 
buffer. This indicated that optimal separation of membranes is achieved by exposing to high-salt 
buffer. We also confirmed that OCTN2 is present in both the plasma membrane and the 
intracellular fraction (Fig. 2B). Following 5 min of electrically induced muscle contraction, the 
OCTN2 content in the OME fraction (F2) was significantly increased (+49%, p < 0.05, Fig. 2B), 
suggesting that OCTN2 was translocated to the plasma membrane. As expected, muscle 
contraction had no effect on MCT4 redistribution (Fig. 2B). 
 
Experiment 3: Effects of muscle contraction on localization of OCTN2 
Immunohistochemical staining of OCTN2 demonstrated that the protein was located in 
or near the sarcolemmal membrane but was also present in the intracellular region (Figs. 3A). 
The control myofibers, which were not incubated with primary antibody, did not exhibit any 
labeling (data not shown).  
In order to investigate changes in the localization of OCTN2 due to muscle contraction, 
cryosections taken from stimulated/unstimulated muscles (GasD) were immunofluorescently 
labeled. As shown in Fig. 3A and 3D, OCTN2 signals were higher on the sarcolemma and around 
the capillary vessels, especially in the contracting leg. Double staining with dystrophin as an 
outer membrane marker (Fig. 3B, 3E) further emphasized the colocalization of OCTN2 with 
dystrophin in contracting muscle (Fig. 3C, 3F).  
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DISCUSSION 
 
The present study is the first investigation to provide experimental evidence that 
contractile activity facilitates carnitine uptake through the translocation of OCTN2 in skeletal 
muscle. In agreement with our hypothesis, (1) electrically induced muscle contraction amplified 
carnitine uptake into muscle cells (Fig. 1, Table 1), but this uptake was independent of changes in 
blood flow; and (2) more OCTN2 protein localized to the plasma membrane in contracting 
muscle (Figs 2, 3). These results suggest that during muscle contraction, carnitine influx in the 
skeletal muscles is facilitated via contraction-induced changes in the subcellular localization of 
the carnitine transporter OCTN2. 
In order to clarify the effect of muscle contraction on carnitine uptake, we performed 
electro-stimulation on rat hindlimb muscles and evaluated carnitine uptake clearance by in vivo 
integration plot analysis (Fig. 1). Our data clearly showed that carnitine uptake clearance was 
about 1.5 fold higher in contracting muscles than in resting muscles, suggesting that muscle 
contraction facilitated carnitine uptake into muscles. These data supports the hypothesis that 
exercise may activate transmembrane influx of carnitine as suggested by Vukovich et al. [7]. 
Some previous studies have also revealed an increase in the serum short-chain acylcarnitine 
concentration during exercise, indicating an efflux of acylcarnitine from the muscles to the blood 
[5,21]. These studies also showed that there is no change in the total muscle carnitine content, 
implying an exchange of free carnitine and carnitine esters between the muscle and blood during 
exercise [7]. The salutary effects of the facilitation of carnitine uptake and acetylcarnitine export 
during muscle contraction were associated with the regulation of acetylcarnitine/free carnitine 
ratio in sarcoplasm. Since muscle free carnitine availability becomes limiting to CPT1 during 
- 15 - 
exercise [6], the facilitation of carnitine turnover in contracting muscles is likely to be involved in 
the maintenance of intracellular free carnitine availability to sustain muscle fat oxidation. 
Although little attention has been paid to transmembrane carnitine transport during muscle 
contraction, the integration plot analysis performed in the present study proved that muscle 
contraction indeed increased carnitine uptake to maintain the free carnitine pool in skeletal 
muscle.  
The blood flow did not affect the carnitine uptake in contracting muscle in the present 
study. In order to examine the impact of blood flow on muscle carnitine uptake, the [
14
C]IAP 
uptake clearance was evaluated. [
14
C]IAP is a rapid diffusible radiolabelled tracer that has been 
used as an index of blood flow [14,15]. The CLuptake of [
14
C]IAP was considerably higher than 
that of L-[
3
H]carnitine even under the resting condition (8–10-fold difference, Table 1). 




H]carnitine did not correlate 
among the 4 calf muscles. We also evaluated the intrinsic clearance, which indicates the ability of 
the organ to take up the substrates from blood in the absence of other confounding factors (such 
as blood flow rate and protein binding). Our results demonstrated that the CLint was 
1.17–1.32-fold greater in the contracting muscles than in resting muscles (Table 1). Taken 
together, these observations proved that carnitine uptake during muscle contraction occurs 
independent of the change in blood flow, suggesting a specific regulatory mechanism via eg. 
carnitine transporter, even though our protocol only considers local blood flow regulation 
induced by electrical stimulation. 
Immunoblot analysis revealed the change in OCTN2 concentration in the sarcolemma 
by a fractionation method [19]. We succeeded in extracting the OME fraction (confirmed by 
MCT4) and quantified the OCTN2 concentration. Our findings showed that muscle contractions 
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resulted in a 49% increase in the OCTN2 content of the sarcolemmal membrane as compared to 
control muscles (Fig. 2B). These biochemical data are consistent with the immunohistochemical 
observation that OCTN2 was intensified to the sarcolemma during muscle contraction (Fig. 3). 
Our hindlimb-perfused fixation technique allowed us to fix the intracellular proteins immediately 
after contraction. Transverse sections obtained from the fixed muscles were double stained with 
antibodies against both OCTN2 and dystrophin (a plasma membrane marker). 
Immunofluorescent staining indicated that OCTN2 was not localized exclusively in the 
sarcolemma of resting muscles. In contrast to the situation in the resting muscle, contracting 
muscles showed sarcolemma-specific expression of OCTN2 and an increased overlapping ratio 
of OCTN2 with dystrophin compared with basal muscles, suggesting translocation of OCTN2 to 
the sarcolemma due to contraction (Fig. 3). Taken together both biochemical and 
immunohistochemical observations supported the hypothesis that OCTN2 was translocated to the 
sarcolemma during muscle contraction. 
In conclusion, this is the first study to show that muscle contraction facilitates carnitine 
uptake in skeletal muscles, independent of the changes in blood flow. Experimental evidence has 
shown that OCTN2 is redistributed from an intracellular location to the surface of the muscle, 
indicating that this protein is translocated in contracting skeletal muscle to upregulate carnitine 
uptake in skeletal muscle. The present study, therefore, provides new insight into the regulation 
of muscle energy metabolism in contracting skeletal muscles.  
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Figure Legends  
 
Figure 1. Comparison between the muscle uptake clearance of L-[
3
H]carnitine by resting 
muscles (open column) and contraction-stimulated muscles (closed column). The 
data were corrected by the radioactivity of [
14
C]inulin, which is a marker of 
vascular and interstitial fluids.  Sol: the soleus, Pla: the plantaris, GasS: surface 
portion of the gastrocnemius, GasD: deep portion of the gastrocnemius. Values are 
presented as means ± SEM (n = 5). *: p < 0.05 vs. resting muscle. 
 
Figure 2. Subcellular localization of OCTN2 and dystrophin in resting (A, B, C) and 
contraction-stimulated (D, E, F) muscles (deep portion of the gastrocnemius). In 
resting muscles, OCTN2 locates on the sarcolemma but also is detected in the 
intracellular space (A). In contrast to resting muscle, images of evoked-contraction 
muscles (D) show sarcolemma-specific expression of OCTN2. Dystrophin is the 
sarcolemmal marker (B and E). Compared with resting muscles (C), the overlap of 
OCTN2 (red) and dystrophin (green) is increased in contracting muscles (F) 
(indicated by arrowheads). Scale bar = 50 µm. 
 
Figure 3. Comparison of OCTN2 expression in the intracellular fraction and the OME 
fraction with/without muscle contraction. 
 A: Representative western blot of the plasma membrane marker (MCT4) in 
Fractions 1–3. When skeletal muscles (GasD) were incubated in high-salt buffer 
[indicated with a plus (+) sign], MCT4 was detected in Fraction 2 but not in 
- 19 - 
Fractions 1 or 3.  
 B: Effect of muscle contraction on OCTN2 and MCT4 protein expression in the 
intracellular fraction and the OME fraction obtained from resting muscles (open 
column) and from contracting muscles (closed column). Representative 
immunoblots are shown above the quantified data. The amount of OCTN2 is 
normalized to GAPDH level. Quantification of OCTN2 for the contracting muscles 
is expressed relative to the contralateral resting muscles from the same animals. 
OME, outer membrane-enriched fraction. Values are presented as means ± SEM (n 
= 6). *: p < 0.05 vs. resting muscle. 
 




C]IAP and Intrinsic clearance.  




 tissue (mean ± SEM), n = 5, Sol: the soleus, Pla: the plantaris, 
GasS: surface portion of the gastrocnemius, GasD: deep portion of the 
gastrocnemius, IAP: iodoantipyrine. *: p < 0.05 vs. resting muscle. 
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